803 filings
Page 15 of 41
4
Power Sean A
19 Jun 17
TG THERAPEUTICS / Sean A Power ownership change
12:00am
4
Echelard Yann
19 Jun 17
TG THERAPEUTICS / Yann Echelard ownership change
12:00am
8-K
TGTX
TG Therapeutics Inc
16 Jun 17
Other Events
12:00am
EFFECT
TGTX
TG Therapeutics Inc
13 Jun 17
Notice of effectiveness
12:00am
CORRESP
TGTX
TG Therapeutics Inc
9 Jun 17
Correspondence with SEC
12:00am
S-3/A
TGTX
TG Therapeutics Inc
Shelf registration (amended)
9 Jun 17
12:00am
8-K
TGTX
TG Therapeutics Inc
5 Jun 17
Other Events
12:00am
S-3
TGTX
TG Therapeutics Inc
Shelf registration
26 May 17
12:00am
8-K
TGTX
TG Therapeutics Inc
24 May 17
TG Therapeutics, Inc. Announces Successful Outcome from Pre-Planned Interim Analysis by Independent DSMB in the UNITY-CLL Phase 3 Trial
12:00am
10-Q
2017 Q1
TGTX
TG Therapeutics Inc
Quarterly report
10 May 17
12:00am
8-K
TGTX
TG Therapeutics Inc
5 May 17
TG Therapeutics, Inc. Provides Business Update and Reports First Quarter 2017 Financial Results
12:00am
8-K
TGTX
TG Therapeutics Inc
1 May 17
TG-1101 was well tolerated with no grade 3/4 adverse events reported, with median time on study of 5 months
12:00am
DEF 14A
TGTX
TG Therapeutics Inc
Definitive proxy
28 Apr 17
12:00am
4
Kennedy William James
12 Apr 17
TG THERAPEUTICS / WILLIAM JAMES KENNEDY ownership change
12:00am
SC 13G/A
FMR LLC
10 Apr 17
TG Therapeutics, Inc.
12:00am
4
Charney Laurence N
4 Apr 17
TG THERAPEUTICS / Laurence N Charney ownership change
12:00am
10-K/A
2016 FY
TGTX
TG Therapeutics Inc
Annual report (amended)
21 Mar 17
12:00am
10-K
2016 FY
TGTX
TG Therapeutics Inc
Annual report
16 Mar 17
12:00am
424B5
TGTX
TG Therapeutics Inc
10 Mar 17
Prospectus supplement for primary offering
12:00am
8-K
TGTX
TG Therapeutics Inc
10 Mar 17
TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2016 Financial Results and Business Update
12:00am